We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$195M
AUM Growth
+$1.58M
(+0.82%)
Cap. Flow
-$2.25M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
95
New
32
Increased
19
Reduced
11
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$7.51M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
+$6.98M |
| 3 |
Pfizer
PFE
|
+$4.9M |
| 4 |
Stryker
SYK
|
+$4.74M |
| 5 |
AbbVie
ABBV
|
+$3.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$9.93M |
| 2 |
Boston Scientific
BSX
|
+$5.18M |
| 3 |
Humana
HUM
|
+$4.9M |
| 4 |
CONMED
CNMD
|
+$4.72M |
| 5 |
AGN
Allergan plc
AGN
|
+$3.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 70.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Perrigo
PRGO
$1.75B
| $3.29M | 1.68% |
+17,125
| New | +$3.26M |
|
|
AFFX
27
DELISTED
Affymetrix Inc
AFFX
| $3.29M | 1.68% |
300,000
+169,883
| +131% | +$2.06M |
|
28
Bausch Health
BHC
$2.37B
| $3.22M | 1.65% |
12,500
-9,500
| -43% | -$2.11M |
|
|
CYNA
29
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $3.15M | 1.61% |
+194,461
| New | +$3.19M |
|
|
WMGI
30
DELISTED
Wright Medical Group Inc
WMGI
| $3.1M | 1.59% |
+120,101
| New | +$3.17M |
|
31
Biogen
BIIB
$30.6B
| $2.95M | 1.51% |
+9,250
| New | +$3.71M |
|
32
PUT
PTC Therapeutics
PTCT
$6.23B
| $2.89M | 1.48% |
60,000
| – | – |
|
|
QGENF
33
DELISTED
QIAGEN NV
QGENF
| $2.8M | 1.43% |
+100,000
| New | +$2.8M |
|
|
KITE
34
DELISTED
Kite Pharma, Inc.
KITE
| $2.62M | 1.34% |
36,000
+8,350
| +30% | +$476K |
|
|
FEIC
35
CALL
DELISTED
FEI COMPANY
FEIC
| $2.58M | 1.32% |
+30,000
| New | +$2.39M |
|
|
RCPT
36
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $2.51M | 1.28% |
11,000
-10,500
| -49% | -$1.74M |
|
|
ASXC
37
DELISTED
Asensus Surgical, Inc.
ASXC
| $2.49M | 1.28% |
58,615
+38,461
| +191% | +$1.77M |
|
|
ALXN
38
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.47M | 1.26% |
12,500
+2,500
| +25% | +$431K |
|
39
Accuray
ARAY
$34.9M
| $2.42M | 1.24% |
+380,000
| New | +$2.83M |
|
|
AGN
40
DELISTED
Allergan Inc
AGN
| $2.32M | 1.19% |
+7,000
| New | +$2.32M |
|
|
SGYP
41
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $2.25M | 1.15% |
246,250
-78,450
| -24% | -$380K |
|
42
Eli Lilly
LLY
$1.1T
| $2.24M | 1.15% |
+26,500
| New | +$2.02M |
|
|
THOR
43
PUT
DELISTED
THORATEC CORPORATION
THOR
| $2.23M | 1.14% |
+50,000
| New | +$2.19M |
|
|
AKRX
44
DELISTED
Akorn Inc
AKRX
| $2.16M | 1.11% |
46,875
-12,125
| -21% | -$561K |
|
|
ESPR
45
PUT
DELISTED
Esperion Therapeutics
ESPR
| $2.14M | 1.09% |
+34,500
| New | +$3.38M |
|
|
ADYX
46
DELISTED
Adynxx Inc
ADYX
| $2.09M | 1.07% |
7,000
+2,917
| +71% | +$862K |
|
|
CPRX
47
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.95M | 1% |
395,000
+30,000
| +8% | +$120K |
|
|
SAGE
48
DELISTED
Sage Therapeutics
SAGE
| $1.91M | 0.98% |
+28,000
| New | +$1.8M |
|
|
SPNC
49
CALL
DELISTED
Spectranetics Corp
SPNC
| $1.73M | 0.88% |
+75,000
| New | +$2.09M |
|
|
NXTM
50
CALL
DELISTED
NxStage Medical Inc.
NXTM
| $1.43M | 0.73% |
+100,000
| New | +$1.69M |
|
Similar funds
BCA
RC
DOFI
SR
SCI
LPC
GBCP
SCTC
Pura Vida Investments's Q2 2015 Portfolio in Review
As of Q2 2015, Pura Vida Investments held 95 positions worth $195M, up 0.82% from $194M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Pura Vida Investments's Q2 2015 filing shows 32 new, 19 increased, 11 reduced and 27 closed positions. Its largest new stake was Universal Health Services: 60,000 shares worth $8.71M. The largest sale was Baxter International, an estimated $9.93M.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 55% a quarter earlier.
- Pura Vida Investments's largest Q2 2015 buy was Universal Health Services: 60,000 shares worth $8.71M.
- Pura Vida Investments added most to Cigna in Q2 2015, an estimated $3.59M increase.
- Pura Vida Investments's biggest Q2 2015 reduction was Boston Scientific, cutting an estimated $5.18M.
- Pura Vida Investments fully exited Baxter International in Q2 2015, selling an estimated $9.93M.
- Pura Vida Investments's ten largest holdings make up 32% of its $195M portfolio in Q2 2015.
- Pura Vida Investments opened 32 new positions and closed 27 in Q2 2015.
- Pura Vida Investments's portfolio value rose 0.82% quarter-over-quarter to $195M.
Based on Pura Vida Investments's 13F filing for Q2 2015, filed 14 Aug 2015.